Choreo LLC’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Sell
47,850
-250
-0.5% -$5.78K 0.01% 586
2026
Q1
$1.15M Buy
48,100
+13,030
+37% +$319K 0.01% 563
2025
Q4
$798K Sell
35,070
-2,763
-7% -$60.1K 0.01% 699
2025
Q3
$762K Buy
37,833
+5,730
+18% +$96K 0.01% 724
2025
Q2
$458K Buy
32,103
+3,778
+13% +$44.2K 0.01% 934
2025
Q1
$297K Sell
28,325
-12,368
-30% -$140K ﹤0.01% 1092
2024
Q4
$481K Sell
40,693
-8,622
-17% -$113K 0.01% 928
2024
Q3
$715K Buy
49,315
+5,373
+12% +$74.9K 0.01% 727
2024
Q2
$620K Buy
+43,942
New +$702K 0.01% 714

Other funds holding ELAN

Choreo LLC's ELAN Position: Q2 2026 in Review

Choreo LLC reduced its Elanco Animal Health (ELAN) stake by 0.52% in Q2 2026, selling an estimated $5.78K and leaving 47,850 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #586.

Choreo LLC first reported a position in ELAN in Q2 2024 and has held it in 9 quarters since. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Choreo LLC held 47,850 shares of Elanco Animal Health worth $1.18M as of Q2 2026.
  • Choreo LLC sold 250 Elanco Animal Health shares in Q2 2026, an estimated $5.78K.
  • Elanco Animal Health made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #586 holding.
  • Choreo LLC first reported a position in Elanco Animal Health in Q2 2024 and has held it in 9 quarters since.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.